Nope, they stopped the ET trial at 20 pts. So other than setting-up ISTs in AML and MDS and monitoring the MF IST, they aren't doing anything. About the only good news in this scenario is that they aren't wasting the $90M chasing solid tumors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.